M&A Deal Summary

Collegium Pharmaceutical Acquires Ironshore Therapeutics

On July 29, 2024, Collegium Pharmaceutical acquired life science company Ironshore Therapeutics for 525M USD

Acquisition Highlights
  • This is Collegium Pharmaceutical’s 3rd transaction in the Life Science sector.
  • This is Collegium Pharmaceutical’s 2nd largest (disclosed) transaction.
  • This is Collegium Pharmaceutical’s 3rd transaction in the United States.
  • This is Collegium Pharmaceutical’s 2nd transaction in North Carolina.

M&A Deal Summary

Date 2024-07-29
Target Ironshore Therapeutics
Sector Life Science
Buyer(s) Collegium Pharmaceutical
Deal Type Add-on Acquisition
Deal Value 525M USD
Advisor(s) Centerview Partners (Financial)
Goodwin Procter (Legal)

Target

Ironshore Therapeutics

Morrisville, North Carolina, United States
Ironshore Therapeutics is a pharmaceutical company providing patient-focused treatment options to improve the lives of patients and caregivers. Ironshore Therapeutics is based in Morrisville, North Carolina.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Collegium Pharmaceutical

Stoughton, Massachusetts, United States

Category Company
Founded 2002
Sector Life Science
Employees197
Revenue 567M USD (2023)
DESCRIPTION

Collegium Pharmaceutical offers specialty pharmaceutical services by developing and planning to commercialize next-generation, abuse-deterrent products for patients suffering from chronic pain. Collegium Pharmaceutical was founded in 2002 and is based in Stoughton, Massachusetts.


DEAL STATS #
Overall 3 of 3
Sector (Life Science) 3 of 3
Type (Add-on Acquisition) 2 of 2
State (North Carolina) 2 of 2
Country (United States) 3 of 3
Year (2024) 1 of 1
Size (of disclosed) 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-02-14 BioDelivery

Raleigh, North Carolina, United States

BioDelivery is a commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions. BDSI has built a portfolio of differentiated pain and neurology products and leverages its experienced sales and marketing organization to educate prescribers on their unique features. BioDelivery was formed in 1997 and is based in Raleigh, North Carolina.

Buy $604M